Nu Skin Enterprises (NUS) Updates Q4 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its fourth quarter earnings guidance on Wednesday morning. The company provided earnings per share guidance of $1.04-1.11 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.13. The company issued revenue guidance of $665-685 million, compared to the consensus revenue estimate of $665.95 million.

Shares of NYSE NUS traded down $8.77 during mid-day trading on Thursday, hitting $64.05. 23,561 shares of the stock were exchanged, compared to its average volume of 409,570. The firm has a market cap of $4.04 billion, a price-to-earnings ratio of 19.87, a PEG ratio of 1.78 and a beta of 1.04. The company has a current ratio of 1.82, a quick ratio of 1.19 and a debt-to-equity ratio of 0.46. Nu Skin Enterprises has a twelve month low of $60.15 and a twelve month high of $88.68.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Wednesday, November 7th. The company reported $0.94 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.96 by ($0.02). Nu Skin Enterprises had a return on equity of 25.67% and a net margin of 5.74%. The firm had revenue of $675.31 million for the quarter, compared to analyst estimates of $664.99 million. During the same period in the previous year, the business posted $0.76 EPS. The business’s quarterly revenue was up 19.8% on a year-over-year basis. On average, analysts forecast that Nu Skin Enterprises will post 3.59 earnings per share for the current year.

Several analysts have recently commented on NUS shares. Zacks Investment Research cut shares of Nu Skin Enterprises from a strong-buy rating to a hold rating in a research note on Monday, October 8th. DA Davidson started coverage on shares of Nu Skin Enterprises in a research note on Tuesday, October 9th. They set a buy rating and a $92.00 price target on the stock. Jefferies Financial Group reissued a buy rating and set a $98.00 price target on shares of Nu Skin Enterprises in a research note on Tuesday, September 4th. Stifel Nicolaus raised shares of Nu Skin Enterprises from a sell rating to a hold rating and increased their price target for the company from $57.00 to $70.00 in a research note on Thursday, August 2nd. They noted that the move was a valuation call. Finally, Citigroup set a $88.00 price target on shares of Nu Skin Enterprises and gave the company a buy rating in a research note on Thursday. One investment analyst has rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of Buy and a consensus target price of $86.29.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, September 4th. The shares were sold at an average price of $79.90, for a total value of $199,750.00. Following the transaction, the general counsel now directly owns 33,871 shares of the company’s stock, valued at $2,706,292.90. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders have sold 8,750 shares of company stock worth $712,100 over the last three months. 5.20% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: “Nu Skin Enterprises (NUS) Updates Q4 Earnings Guidance” was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international copyright and trademark laws. The correct version of this piece of content can be viewed at

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

Read More: How is inflation measured?

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with's FREE daily email newsletter.

Leave a Reply